These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 17065922)

  • 1. The ocular manifestations of inflammatory bowel disease.
    Taylor SR; McCluskey P; Lightman S
    Curr Opin Ophthalmol; 2006 Dec; 17(6):538-44. PubMed ID: 17065922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel therapeutic options in the inflammatory bowel disease world.
    Noble A; Baldassano R; Mamula P
    Dig Liver Dis; 2008 Jan; 40(1):22-31. PubMed ID: 17988966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence-based medications for the treatment of the inflammatory bowel diseases.
    De La Rue SA; Bickston SJ
    Curr Opin Gastroenterol; 2006 Jul; 22(4):365-9. PubMed ID: 16760751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ophthalmological aspects of IBD.
    Manganelli C; Turco S; Balestrazzi E
    Eur Rev Med Pharmacol Sci; 2009 Mar; 13 Suppl 1():11-3. PubMed ID: 19530506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of immune-mediated extraintestinal manifestations of inflammatory bowel disease with infliximab.
    Barrie A; Plevy S
    Gastroenterol Clin North Am; 2006 Dec; 35(4):883-93. PubMed ID: 17129819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological therapies in inflammatory bowel disease: top-down or bottom-up?
    Oldenburg B; Hommes D
    Curr Opin Gastroenterol; 2007 Jul; 23(4):395-9. PubMed ID: 17545775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous manifestations in inflammatory bowel diseases: eight cases of psoriasis induced by anti-tumor-necrosis-factor antibody therapy.
    Passarini B; Infusino SD; Barbieri E; Varotti E; Gionchetti P; Rizzello F; Morselli C; Tambasco R; Campieri M
    Dermatology; 2007; 215(4):295-300. PubMed ID: 17911986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppression in inflammatory bowel disease: traditional, biological or both?
    Van Assche G; Vermeire S; Rutgeerts P
    Curr Opin Gastroenterol; 2009 Jul; 25(4):323-8. PubMed ID: 19417645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of chronic inflammatory bowel diseases].
    Lémann M
    Bull Acad Natl Med; 2007 Jun; 191(6):1125-41; discussion 1141. PubMed ID: 18402168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review article: steroid resistance in inflammatory bowel disease - mechanisms and therapeutic strategies.
    Creed TJ; Probert CS
    Aliment Pharmacol Ther; 2007 Jan; 25(2):111-22. PubMed ID: 17229236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inflammatory bowel diseases].
    Felley C; Guyot J; Hess J; Mottet C; Delarive J; Michetti P
    Rev Med Suisse; 2005 Jan; 1(3):218-20, 223-7. PubMed ID: 15770816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on ocular graft versus host disease.
    Kim SK
    Curr Opin Ophthalmol; 2006 Aug; 17(4):344-8. PubMed ID: 16900025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory bowel disease: thinking outside of the intestines (Part 1).
    Ricker JM; Harrison SA
    J Miss State Med Assoc; 2008 Dec; 49(12):359-64. PubMed ID: 19297931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seronegative spondyloarthropathies and the eye.
    Ali A; Samson CM
    Curr Opin Ophthalmol; 2007 Nov; 18(6):476-80. PubMed ID: 18162999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory bowel disease. 2. Current and future therapeutic options.
    Moses PL; Moore BR; Ferrentino N; Bensen SP; Vecchio JA
    Postgrad Med; 1998 May; 103(5):86-90, 95-7, 101-2. PubMed ID: 9590988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dry eyes: etiology and management.
    Latkany R
    Curr Opin Ophthalmol; 2008 Jul; 19(4):287-91. PubMed ID: 18545008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in drug delivery systems for treating ocular complications of systemic diseases.
    Lee SS; Hughes PM; Robinson MR
    Curr Opin Ophthalmol; 2009 Nov; 20(6):511-9. PubMed ID: 19667987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory bowel diseases in the elderly.
    Swaroop PP
    Clin Geriatr Med; 2007 Nov; 23(4):809-21, vi. PubMed ID: 17923339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular manifestations of inflammatory bowel disease.
    Thomas AS; Lin P
    Curr Opin Ophthalmol; 2016 Nov; 27(6):552-560. PubMed ID: 27585211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis and clinical approach to extraintestinal manifestations of inflammatory bowel disease.
    Agrawal D; Rukkannagari S; Kethu S
    Minerva Gastroenterol Dietol; 2007 Sep; 53(3):233-48. PubMed ID: 17912186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.